Clinical Trials
4
Active:3
Completed:0
Trial Phases
1 Phases
Phase 1:4
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Phase 1
4 (100.0%)Clinical Trial of SOT102 Antibody Drug Conjugate in Patients With Advanced Gastric and Pancreatic Adenocarcinoma
- First Posted Date
- 2022-09-01
- Last Posted Date
- 2025-01-13
- Lead Sponsor
- SOTIO Biotech a.s.
- Target Recruit Count
- 44
- Registration Number
- NCT05525286
- Locations
- 🇺🇸
Washington University School of Medicine in St. Louis, Saint Louis, Missouri, United States
🇺🇸Cleveland Clinic Main Campus, Cleveland, Ohio, United States
🇧🇪Institut Jules Bordet, Brussels, Belgium
News
No news found